Synchronous splenectomy and hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A case-control study

Table 1 Demographic data of the hepatectomy and splenectomy group and the hepatectomy alone group

Variable	HS group	HA group	P value
Number of patients (n)	84	84
Age (yr)	49.32 ± 10.485	51.01 ± 10.830	0.306
Gender (M/F)	69:15	69:15	1.000
HBsAg (positive/negative)	71:13	72:12	0.828
AFP (ng/mL)			0.633
≤ 400	54	51
> 400	30	33
White blood cell count (109/L)	3.96 ± 4.11	4.60 ± 4.41	0.332
Platelet count (109/L)	61.43 ± 42.113	68.93 ± 17.677	0.134
Splenomegaly(mild/moderate/severe)	12:46:36	14:53:27	0.380
Chlid-Pugh class (A)	84	84
Number of tumors
Single	11	11	1.000
Multiple	73	73
Diameter of tumor (cm)
Mean	4.18 ± 2.134	4.26 ± 1.996	0.809
≤ 5	13	18	0.320
> 5	71	66
Micro-vascular invasion
Yes	20	22	0.722
No	64	62

HS: Hepatectomy and splenectomy; HA: Hepatectomy alone; AFP: Alpha-fetoprotein; HBsAg: Hepatitis B surface antigen.